Community engagement and the social context of targeted malaria treatment: a qualitative study in Kayin (Karen) State, Myanmar

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Sahan, Kate ^a   Pell, Christopher ^b,e   Smithuis, Frank ^c,d   Phyo, Aung Kyaw ^c   Maung, Sai Maung ^c   Indrasuta, Chanida ^c   Dondorp, Arjen M ^d   White, Nicholas J ^d   Day, Nicholas P J ^d   Von Seidlein, Lorenz ^d   Cheah, Phaik Yeong ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Medical Action Myanmar   (Myanmar)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

Author keywords

Community engagement; Elimination; Malaria; Mass drug administration

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ASYMPTOMATIC INFECTION; ATTITUDE TO HEALTH; COMMUNITY PARTICIPATION; ETHNICITY; FAMILY DECISION MAKING; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; LOW DRUG DOSE; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MYANMAR; POVERTY; QUALITATIVE RESEARCH; RELIGION; RURAL POPULATION; SEMI STRUCTURED INTERVIEW; SINGLE DRUG DOSE; SOCIAL ENVIRONMENT; SOCIAL STATUS; TRADITIONAL MEDICINE; TRUST; PSYCHOLOGY;

ANTIMALARIALS; COMMUNITY PARTICIPATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; MALARIA; MYANMAR;

EID: 85012865049     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1718-y     Document Type: Article

References (24)

1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619-20.
2. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
3. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960-6.
4. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415-21.
5. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272-80.
6. WHO. Strategy for malaria elimination in the Greater Mekong subregion: 2015-2030. Geneva: World Health Organization. http://www.wpro.who.int/mvp/documents/en/. Accessed 18 Aug 2016.
7. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715-30.
8. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
9. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;(12):1-160. doi:10.1002/14651858.CD008846.pub2.
10. Wellcome Trust. Artemisinin-resistant malaria close to Myanmar-India border. 2015. https://wellcome.ac.uk/press-release/artemisinin-resistant-malaria-close-myanmar-india-border. Accessed 23 Jan 2017.
11. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000;356:1560-4.
12. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007;4:e273.
13. Centers for Disease Control and Prevention. Principles of community engagement (2nd ed.). Atlanta (GA): Centers for Disease Control/Agency for Toxic Substance and Disease Registry Committee on Community Engagement; 2011. https://www.atsdr.cdc.gov/communityengagement/index.html. Accessed 23 Jan 2017.
14. Nguyen TN, Thu PN, Hung NT, et al. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey. Malar J. 2017;16:17.
15. Dial NJ, Ceesay SJ, Gosling RD, D’Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014;13:47.
16. Njomo DW, Mukoko DA, Nyamongo NK, Karanja J. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya. PLoS ONE. 2014;9:e83413.
17. MAM. Medical Action Myanmar. http://medicalactionmyanm.wix.com/medicalactionmyanmar. Accessed 18 Aug 2016.
18. Guyant P, Canavati SE, Chea N, Ly P, Whittaker MA, Roca-Feltrer A, et al. Malaria and the mobile and migrant population in Cambodia: a population movement framework to inform strategies for malaria control and elimination. Malar J. 2015;14:252.
19. Grietens KP, Gryseels C, Dierickx S, Bannister-Tyrrell M, Trienekens S, Uk S, et al. Characterizing types of human mobility to inform differential and targeted malaria elimination strategies in Northeast Cambodia. Sci Rep. 2015;5:16837.
20. Atkinson JA, Vallely A, Fitzgerald L, Whittaker M, Tanner M. The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J. 2011;10:225.
21. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303-9.
22. MacQueen KM, Bhan A, Frohlich J, Holzer J, Sugarman J. Ethics Working Group of the HIVPTN. Evaluating community engagement in global health research: the need for metrics. BMC Med Ethics. 2015;16:44.
23. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med. 2005;61:1463-73.
24. Kajeechiwa L, Thwin MM, Shee PW, et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016;15:494.